| Year |
Citation |
Score |
| 2018 |
Ma H, Russek-Cohen E, Izem R, Marchenko OV, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Transforming Data Into Evidence. Therapeutic Innovation & Regulatory Science. 52: 187-198. PMID 29714524 DOI: 10.1177/2168479018755085 |
0.361 |
|
| 2018 |
Izem R, Sanchez-Kam M, Ma H, Zink R, Zhao Y. Sources of Safety Data and Statistical Strategies for Design and Analysis: Postmarket Surveillance. Therapeutic Innovation & Regulatory Science. 52: 159-169. PMID 29714520 DOI: 10.1177/2168479017741112 |
0.338 |
|
| 2018 |
Zink RC, Marchenko O, Sanchez-Kam M, Ma H, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials. Therapeutic Innovation & Regulatory Science. 52: 141-158. PMID 29714519 DOI: 10.1177/2168479017738980 |
0.387 |
|
| 2017 |
Marchenko O, Jiang Q, Chuang-Stein C, Mehta C, Levenson M, Russek-Cohen E, Liu L, Sanchez-Kam M, Zink R, Ke C, Ma H, Maca J, Park S. Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus Statistics in Biopharmaceutical Research. 9: 347-360. DOI: 10.1080/19466315.2017.1280411 |
0.35 |
|
| 2016 |
Zhao H, Hobbs BP, Ma H, Jiang Q, Carlin BP. Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors. Health Services & Outcomes Research Methodology. 16: 154-171. PMID 28458614 DOI: 10.1007/S10742-016-0155-7 |
0.607 |
|
| 2016 |
Zhao H, Hodges JS, Ma H, Jiang Q, Carlin BP. Hierarchical Bayesian approaches for detecting inconsistency in network meta-analysis. Statistics in Medicine. PMID 27037506 DOI: 10.1002/Sim.6938 |
0.556 |
|
| 2016 |
Ma H, Jiang Q, Chuang-Stein C, Evans SR, He W, Quartey G, Scott J, Wen S, Arani R. Considerations on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment of Medical Product Statistics in Biopharmaceutical Research. 8: 417-425. DOI: 10.1080/19466315.2016.1234974 |
0.302 |
|
| 2015 |
Ma H, Ke C, Jiang Q, Snapinn S. Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials. Therapeutic Innovation & Regulatory Science. 49: 957-965. PMID 30222385 DOI: 10.1177/2168479015587363 |
0.301 |
|
| 2015 |
Marchenko O, Jiang Q, Chakravarty A, Ke C, Ma H, Maca J, Russek-Cohen E, Sanchez-Kam M, C. Zink R, Chuang-Stein C. Evaluation and Review of Strategies to Assess Cardiovascular Risk in Clinical Trials in Patients with Type 2 Diabetes Mellitus Statistics in Biopharmaceutical Research. 7: 253-266. DOI: 10.1080/19466315.2015.1077724 |
0.319 |
|
| 2014 |
Ohlssen D, Price KL, Xia HA, Hong H, Kerman J, Fu H, Quartey G, Heilmann CR, Ma H, Carlin BP. Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis. Pharmaceutical Statistics. 13: 55-70. PMID 24038897 DOI: 10.1002/Pst.1592 |
0.609 |
|
| 2011 |
Xia HA, Ma H, Carlin BP. Bayesian hierarchical modeling for detecting safety signals in clinical trials. Journal of Biopharmaceutical Statistics. 21: 1006-29. PMID 21830928 DOI: 10.1080/10543406.2010.520181 |
0.554 |
|
| 2010 |
Ma H, Carlin BP, Banerjee S. Hierarchical and joint site-edge methods for medicare hospice service region boundary analysis. Biometrics. 66: 355-64. PMID 19645704 DOI: 10.1111/J.1541-0420.2009.01291.X |
0.501 |
|
| 2007 |
Ma H, Carlin BP. Bayesian multivariate areal wombling for multiple disease boundary analysis Bayesian Analysis. 2: 281-302. DOI: 10.1214/07-Ba211 |
0.535 |
|
| 2006 |
Virnig BA, Ma H, Hartman LK, Moscovice I, Carlin B. Access to home-based hospice care for rural populations: Identification of areas lacking service. Journal of Palliative Medicine. 9: 1292-9. PMID 17187537 DOI: 10.1089/Jpm.2006.9.1292 |
0.439 |
|
| Show low-probability matches. |